5-(3-fluoro-3-naphthalen-1-yloxypropyl)-3-(1,3,5-trimethylpyrazol-4-yl)-1H-indole-2-carboxylic acid
C28H26FN3O3 — CID 118340056
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(3-fluoro-3-naphthalen-1-yloxypropyl)-3-(1,3,5-trimethylpyrazol-4-yl)-1H-indole-2-carboxylic acid
5-(3-fluoro-3-naphthalen-1-yloxypropyl)-3-(1,3,5-trimethylpyrazol-4-yl)-1H-indole-2-carboxylic acid (PubChem CID 118340056) has the molecular formula C28H26FN3O3 and a molecular weight of 471.53 g/mol. Its IUPAC name is 5-(3-fluoro-3-naphthalen-1-yloxypropyl)-3-(1,3,5-trimethylpyrazol-4-yl)-1H-indole-2-carboxylic acid.
Molecular Properties
| Compound Name | 5-(3-fluoro-3-naphthalen-1-yloxypropyl)-3-(1,3,5-trimethylpyrazol-4-yl)-1H-indole-2-carboxylic acid |
|---|---|
| PubChem CID | 118340056 |
| Molecular Formula | C28H26FN3O3 |
| Molecular Weight | 471.53 g/mol |
| Exact Mass | 471.20 |
| IUPAC Name | 5-(3-fluoro-3-naphthalen-1-yloxypropyl)-3-(1,3,5-trimethylpyrazol-4-yl)-1H-indole-2-carboxylic acid |
| SMILES | Cc1nn(C)c(C)c1-c1c(C(=O)O)[nH]c2ccc(CCC(F)Oc3cccc4ccccc34)cc12 |
| InChI | InChI=1S/C28H26FN3O3/c1-16-25(17(2)32(3)31-16)26-21-15-18(11-13-22(21)30-27(26)28(33)34)12-14-24(29)35-23-10-6-8-19-7-4-5-9-20(19)23/h4-11,13,15,24,30H,12,14H2,1-3H3,(H,33,34) |
| InChIKey | OPLWCAREOHLRIS-UHFFFAOYSA-N |
| XLogP | 6.34 |
| TPSA | 80.14 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 471.53 |
| LogP ≤ 5 | 6.34 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118340056 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.